Looking to list your PhD opportunities? Log in here.
This project is no longer listed on FindAPhD.com and may not be available.
Click here to search FindAPhD.com for PhD studentship opportunitiesAbout the Project
The cystic fibrosis transmembrane conductance regulator (CFTR) anion channel mediates chloride and bicarbonate secretion across various epithelia in the body. Bicarbonate is essential for optimal function of various luminal secretions. As a result, people with cystic fibrosis (CF), i.e. people with little or no CFTR activity, suffer symptoms affecting many organ systems. The development of CFTR modulator drugs has transformed the care of many people with CF. These drugs are divided in two categories: (1) potentiators that improve the ion-channel function of CFTR, and (2) correctors that increase the amount of CFTR at the plasma membrane. So far, development of these has been driven by assays monitoring compound-induced changes in chloride permeation, whereas restoration of bicarbonate transport is seldom taken into account. However, it is conceivable that CF-causing mutations will have distinct consequences for chloride and bicarbonate transport, and that modulators have different effects on CFTR-mediated bicarbonate vs. chloride transport. Also, it is largely unclear whether CFTR modulators can restore bicarbonate secretion in all CF-affected tissues, in particular those that are rarely used as model systems in drug development (e.g. biliary epithelium). The aim of this project is to increase our knowledge of CFTR-dependent bicarbonate secretion, in the hope that a better understanding of its role in the pathophysiology of the disease may ultimately improve pharmacological treatment of people with CF. In this project, we will use advanced stem-cell, biochemical, molecular biology and genomics-based technologies to investigate epithelial bicarbonate secretion and luminal pH regulation, and use the organoid platform to develop new methods to assess (CFTR-dependent) bicarbonate secretion in CF-affected gastro-intestinal tissues, and to assess the effect of modulator therapy on CFTR function.
The PhD studentship is available to start in early 2023. Informal enquiries can be sent to Dr Marcel Bijvelds ([Email Address Removed]).
For more information see also https://www.erasmusmc.nl/en/research/departments/gastroenterology-hepatology
You can view more PhD studentships here: https://www.findaphd.com/phds/program/4-fully-funded-interdisciplinary-phd-studentships/?p5828
Funding Notes
References
Bijvelds MJC, Roos FJM, Meijsen KF, Roest HP, Verstegen MMA, Janssens HM, et al. Rescue of chloride and bicarbonate transport by elexacaftor-ivacaftor-tezacaftor in organoid-derived CF intestinal and cholangiocyte monolayers. J Cyst Fibros. 2021.
Open days

Search suggestions
Based on your current searches we recommend the following search filters.
Check out our other PhDs in Rotterdam, Netherlands
Check out our other PhDs in Netherlands
Start a New search with our database of over 4,000 PhDs

PhD suggestions
Based on your current search criteria we thought you might be interested in these.
Assessing the pathogenesis of pulmonary fibrosis using patient-derived induced pluripotent stem cell models
Royal College of Surgeons in Ireland
Mechanistic understanding of how Non-Alcoholic Fatty Liver disease (NAFLD) can lead to cardiovascular dysfunction using induced pluripotent stem cell (iPSC) derived cardiomyocytes and hepatocytes.
University of Liverpool
SELF-FUNDING MSc BY RESEARCH PROJECT: Cystic fibrosis: restoring ion transport with small molecules
University of Bristol